The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Treatment Results by Uneven Fractionated Irradiation, Low-Dose Rate Telecobalt Therapy as a Boost, and Intraoperative Irradiation for Malignant Glioma
SHOGO YAMADAYOSHIHIRO TAKAIKENJI NEMOTOYOSHIHIRO OGAWAYOSHIHISA KAKUTOAKIHIKO HOSHIKIYOHIKO SAKAMOTOTAKAMASA KAYAMATAKASHI YOSHIMOTO
Author information
JOURNAL FREE ACCESS

1992 Volume 167 Issue 4 Pages 259-266

Details
Abstract
YAMADA, S., TAKAI, Y., NEMOTO, K., OGAWA, Y., KAKUTO, Y., HOSHI, A., SAKAMOTO, K., KAYAMA, T. and YOSHIMOTO, T. Treatment Results by Uneven Fractionated Irradiation, Low-Dose Rate Telecobalt Therapy as a Boost, and Intraoperative Irradiation for Malignant Glioma. Tohoku J. Exp. Med., 1992, 167 (4), 259-266-The prognosis of malignant glioma is extremely poor. We applied conventionally fractionated irradiation combined with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU), uneven fractionated irradiation with ACNU, low dose rate telecobalt therapy as a boost, and intraoperative irradiation against 110 malignant gliomas to investigate the efficacy of these methods as alternative treatments for malignant glioma. Although local tumor control by uneven fractionated irradiation was better than that by the other methods, no significant improvement was obtained in survival rates. As a result of multiple regression analysis, age and histology were major factors for survival rates, and the difference of treatment methods was not important. Both low-dose rate telecobalt therapy as a boost and intraoperative irradiation showed little advantage because of the high risk of brain necrosis associated with them.-malignant glioma; uneven fractionated irradiation; low dose rate irradiation; intraoperative irradiation; 1-(4-amino-2-methyl-5-pyrimidimyl)methyl-3-(2-chloroethyl)-3-nitrosourea
Content from these authors
© Tohoku University Medical Press
Previous article Next article
feedback
Top